In a field of cephalosporin, cefaclor (1)1} and cefroxadine2) are well known antibiotics in which a heteroatom is attached directly at the 3-position. These compoundshave stronger antibacterial activity than cephalexin, which is the 3-methyl analog, because the cephem nucleus is activated by the effects of the substituent at the 3-position.
Wepreviously reported the synthesis and antibacterial activity of KT-3777 (2)3>4) which is a carbacephem with a chlorine atom at the 3-position. KT-3777 showed comparable antibacterial activity and pharmacokinetics in mouse and rat with cefaclor, and was far superior in chemical stability. In this paper, we described the synthesis and antibacterial activity of the compounds in which a heteroatom, particularly the heterocyclic thio group, was introduced at the 3-position by taking advantage of the excellent stability of carbacephem nucleus. The substituent of cephalosporin at the 10-position not only affects the antibacterial activity, but often modifies pharmacokinetics and also contributes to the stability against /3-lactamase5). In this respect, the direct substitution of a heteroatom at the 3-position instead of the 10-position would be of great interest.
Chemistry
An important intermediate 7 was prepared by the method outlined in Scheme 1 starting from 3 which is available in large quantity through the development of a practical synthetic procedure6).
Protected 3-H carbacephem 3 was reacted with one equivalent of iV-bromosuccinimide in water and THFto afford a mixture of three components.The massspectra of three compounds showed the same molecular ion peak at m/z 408 and 410, and the chemical shift of C-3 carbon of each compound appeared around 50 ppm in 13C NMR,the substituent of the 3-position was considered to be bromine in all compounds. According to above data, three compounds were stereoisomers of bromohydrin 4. Interestingly enough, treatment of this mixture with catalytic to equivalent amount of triethylamine did not give epoxide 5, but converted it into one isomer 4a which was the minor component of three isomers. The stereochemistry of 4a could not be decided from its analytical data. However, we postulated 4a as 3-/3-Br and 4-a-OH in twisted chair form of tetrahydropyridine ring judged from the fact that the coupling pattern of 3-H was different from those of other two isomers in 2H NMR,and presumed favorable attack of bromonium ion from less hinderd a-face. Epoxidation of 4a was smoothly effected using l, 8-diazabicyclo[5.4.0] undecen to give 5 as single product in almost quantitative yield. The stereochemistry of 5 was considered to be a-epoxide from the configuration of 4a. Epoxide 5 was also obtained as single crystals from a mixture of three isomers 4. Isomerization of expoxide to ketone was performed by treating 5 with catalytic amount of TsOHin toluene at 110°C to give 6 in 73% yield. The 3-hydroxy derivative of carbacephem has been prepared and reported to be extremely unstable70. Surprisingly 3-hydroxy carbacephem 6 turned out to be very stable, and formed mesylate 7 in good yield. Recently, the alternative synthetic procedure of 3-hydroxy carbacephem was reported8~10). The mesylate 7 reacted readily with various nucleophile to produce 3-substituted carbacephem compounds 8. For example, treatment of 7 with NaN3 in DMFgave 3-azido derivative 8a in 87% yield. As a typical heterocyclic thio group, 5-mercapto-1-methyltetrazole was selected and reacted with 7 in the presence of NaHin DMFto afford 8b in 58 % yield. A phenylglycyl group was selected as an acyl group to the 7-amino group to measure the antibacterial activity. The phenylglycyl derivatives 14 with optically active nucleus were prepared by the efficient route shown in Scheme 2. Treatment of 7 with trifluoroacetic acid gave carboxylic acid9.
Dephthalization of 9 was accomplished with methylhydrazine in an aqueous median) to afford deprotected zwitterion 10 in 68% yield. Racemic mixture of zwitterion 10 was incubated with immobilized enzyme, penicillin acylase obtained from Kluyvera citrophila1^, and D-phenylglycine methyl ester at 30°C adjusting to pH 7.5 with 1 n KOHto give rise to ll in 38% yield. In :H NMRll showed a signal of one of the two kinds of diastereomer which were formed by chemical phenylglycylation of 10. This suggested that enzymatic phenylglycylation proceeds stereoselectively in these carbacephem nucleus. Protected product 12 was obtained in 87% yield by protecting the amino group with ter/-butoxycarbonyl group and carboxylic moiety with benzhydryl group. The compound 12 reacted with thiolate as readily as 7 to give 13 followed by deprotection using trifluoroacetic acid and
anisole to obtain 14 in 30 to 55% yield and Table 1 shows the physical data of 14. Several corresponding cephalosporins were prepared applying the reported procedure13) as shown in Scheme 3 to compare antibacterial activity and chemical stability. That is cefaclor (1) was protected in the same way as carbacephem to give 15. The reaction of 15 with thiol compoundin the presence of NaHSO3in DMFto afford 16. Deprotection of 16 using trifluoroacetic acid and anisole, and adjusting pH to 3.5 gave 17.
Antibacterial Activity As shown in Table 2 , cephalosporins 17a and 17b were extremely unstable, and decomposed rapidly under even neutral condition, while the corresponding carbacephem 14 showed excellent stability. This result suggests that compoundswith a heterocyclothio group at the 3-position are taking full advantage of the good stability of carbacephem nucleus. The comparative antibacterial activities of carbacephem compounds 14 and cephalosporins 17 are summarized in Tables 3 and 4 . Most compounds were more active against Gram-positive and Gram-negative organisms than cefaclor and 3-H carbacephem compound, the mother compound. In paticular, 14f was active against indole positive Proteus with the MICof 1.56 to 3.13^g/ml. As shown in Table 4 , these compounds were strongly active against Enterococcus faecalis which is resistant to most cephalosporins including cefaclor, especially 14e was very potent against most clinical isolate strains of E. faecalis tested.
Wefound interesting properties in carbacephems with heterocyclothio group at the 3-position and further studies are in progress to evaluate these compounds. Experimental 2H NMRspectra were recorded at 90 MHzon a Varian EM-390NMRspectrometer and at 100 MHzon a Jeol-FX-100 NMRspectrometer using TMSor DSSas an internal standard. All chemical shifts are reported in d ppm. IR spectra were taken on a Jasco IR-810 IR spectrometer. Mass spectra were recorded on a Hitachi M-80Bmass spectrometer, secondary ion mass spectra (SI-MS). Estimation of purity of analogues was greater than 95 % by analytical HPLC. Antibiotic Susceptibility All antibacterial activity data are given as the MIC in^g/ml. MICs were determined by the agar dilution method using Mueller-Hinton agar after incubation at 37°C for 20 hours with an inoculum size of about 106 cfu/ml.
ter^-Butyl ( d= )-c/5(-7-Phthalimido-3-bromo-2-hydroxy-
To a suspension of tert-butyl ( ±)-c/,si-7-phthalimidol -azabicyclo[4.2.0]oct-2-en-8-oxo-2-carboxylate (3, 3.68 g) in 80 ml of THF and 20 ml of water was added portionwise 1.66 g of iV-bromosuccinimide (NBS) over 1 hour. The reaction mixture was stirred for 2 hours at room temperature. The reaction mixture was extracted twice with EtOAcand the organic layer was washed with water and brine and evaporated under reduced pressure. The residue was dissolved in 100 ml of CHC13and 0.5 ml of triethylamine was added to the solution. The reaction mixture was stirred for overnight at room temperature, washed with water, dilute HC1 and brine. The solvent was evaporated to give the residue, which was crystallized from hexane -EtOAc (1 : 1) to afford 4a as colorless crystals (3. tert-Butyl ( z£)-cfc-7-Phthalimido-2,3-epoxyl -azabicyclo[4.2.0]octan-8-oxo-2-carboxylate (5) To a suspension of 18.4g of 3 in 400ml of THFand 100ml of water, was added portionwise 8.3 g of NBSover 1 hour with vigorous stirring. The reaction mixture was stirred for 2 hours at room temperature. After addition of 400 ml of EtOAc, the organic layer was separated, washed with water and brine, dried over Na2SO4and evaporated under reduced pressure. The residue was dissolved in 300 ml of CHC13and 7.0 ml of l,8-diazabicyclo[5.4.0]undecen (DBU) was added to the solution under ice-cooling. The reaction mixture was stirred for 2 hours at room temperature and washed with water, 10%citric acid solution and brine. The solvent was evaporated to give the residue, which was crystallized from hexane -EtOAc ( ter/-Butyl ( d=)-c^-7-Phthalimido-3-hydroxyl -azabicyclo[4.2.0]oct-2-en-8-oxo-2-carboxylate (6) A suspension of 12.2 g of 5 and catalytic amount ofi?-TsOH in 245 ml of toluene was heated for 20 minutes at 1 10°C. After cooling to room temperature, the reaction mixture was diluted with EtOAc, washed with water, saturated NaHCO3solution and brine, dried over Na2SO4and evaporated to afford ter/-Butyl ( dz )-cfc-7-Phthalimido-3-mesyloxyl -azabicyclo[4.2.0]oct-2-en-8-oxo-2-carboxylate (7) To a solution of ll.6 g of 6 in 230 ml of CH2C12were added 2.8 ml of methansulfonylchloride and 5.0 ml of triethylamine at -50°C, and the reaction mixture was stirred for 1 hour at room temperature. The reaction mixture was diluted with CHC13, washed with water, 10% citric acid solution, water and saturated NaHCO3solution successively, dried over Na2SO4 and evaporated. The residue was crystallized from hexane -EtOAc (1 : 1) to afford 9.2 g of 7 (89.3%): XH NMR(CDC13) 3 7.8 (4H, m), 5.60 (1H, d), 4.0 (1H, m), 3.27 (3H, s), 2.8-1.8 (4H, m), 1.57 (9H, s); IR (KBr) cm"1 1800, 1790, 1775,1725. tert-Butyl ( ib )-c^-7-Phthalimido-3-azidol -azabicyclo[4.2.0]oct-2°en-8-oxo-2-carboxylate (8a) To a solution of 600 mg of7 in 10 ml ofDMFwas added 150 mg of sodium azide. The reaction mixture was stirred for 1 hour at room temperature and evaporated. The residual solid was dissolved in EtOAc and the solution was washed with water, saturated NaHCO3solution and brine, dried over FEB. 1989 Na2SO4and evaporated. The residue was subjected to column chromatography on silica gel eluting with hexane -EtOAc (1 : 1) to give 8a as yellow crystals (472 mg, 89%): XH NMR(CDC13) d 7.8 (4H, m), 5.60 (1H, d), 3.9 (1H, m), 2.7-1.8 (4H, m); IR (KBr) cm "1 2120, 1795, 1780, 1740, 1725 .
To a suspension of 360 mg of sodium hydride (50%) in 10 ml of dried DMFwere added 1.2 g of l-methyl-5-mercapto-l,2,3,4-tetrazole and 1.2 g of 7 under ice cooling. After stirring for 18 hours at room temperature, the reaction mixture was concentrated to dryness. The residue was dissolved in 100 ml of CHC13, and the solution was washed with water, dried over Na2SO4 and evaporated. The product was purified by column chromatography on silica gel, eluting with CHC13to afford 0.89 g (69%) of8b as colorless powder: AH NMR(CDC13) 8 7.8 (4H, m), 5.67 (1H, d), 4.10 (3H, s), 3.9 (1H, m), 2.9-1.8 (4H, m), 1.56 (9H, s).
( ±)-£fc-7-Amino-3-mesyloxy-l -azabicyclo[4.2.0]oct-2-en-8-oxo-2-carboxylic Acid (10) Mesylate 7 (4.6 g) was dissolved in 10 ml of trifluoroacetic acid and 10 ml of CH2C12 and reacted for 1 hour at room temperature. The reaction mixture was concentrated to dryness under reduced pressure. The residual solid was suspended in 220 ml of water and the pH was adjusted to 7 with saturated NaHCO3 solution. To the suspension was added dropwise 0.83 ml of methylhydrazine over 45 minutes under ice cooling. The reaction mixture was stirred for 3 hours at roomtemperature and acidified to pH 1 with cone HC1. After removal of precipitates by filtration, the filtrate was adjusted to pH 3.5 with suturated NaHCO3solution and concentrated to 50 ml. The solution was stood for over night in refrigerator to give 10 as colorless crystals (1.82 g, 66.2%):^NMR(D2O -NaOD) To a solution of 460 mg of 10 and 1.5 g of phenylglycine methyl ester hydrochloride in 20 ml of 1/10 m phosphate buffer (pH 7.0) was added 10 ml of immobolized enzyme having a penicillin acylase activity. The reaction mixture was incubated at 30°C for 1.5 hours while adjusting the mixture to pH 7.0 with 1 n KOH. The immobilized enzyme was removed by filtration, and the filtrate was adjusted to pH 3.0 with 1 n HC1, and concentrated to about 5 ml. After removal of precipitate by filtration, the filtrate was chromatographed on Diaion HP-10 with eluting by 30% aqueous MeOH To a solution of 1.36g of ll in 20ml of THF and 20ml of water adjusting to pH 7.0 with aq NaHCO3 was added dropwise 1.5 g of di-ter/-butyl-dicarbonate in 4 ml of THF. After stirring for 2 hours at room temperature, 50 ml of EtOAc was added to the reaction mixture. The aqueous layer was acidified with 1 n HC1 to pH 1.9 and extracted twice with EtOAc. The organic layer was collected, washed with water and brine, dried over Na2SO4 and evaporated. The residue was dissolved in 20ml of CHC13, and 1.5 g of diphenyldiazomethane was added to the solution. The reaction mixture was stirred 30 minutes and evaporated. The product was purified by column chromatography on silica gel to afford 12 as colorless powder (1.42 g, 63.3%): XH NMR(CDC13) d 7. 5-7.2 (15H, m), 6.90 (1H, s), 6.8 (1H, d), 5.65 (1H, d), 5.37 (1H, dd), 5.16 (1H, d), 3.8 (1H, m) , 2.83 (3H, s), 2.7-2.4 (2H, m), 1.38 (9H, s), 1.9-1.3 (2H, m) .
General Procedure for the Synthesis of 14 To a solution of 1 mmol ofNaH and 1 mmol ofthiol in 5 ml ofDMFwas added 0.5 mmol of 12. The reaction mixture was stirred for 2 to 16 hours at room temperature to 60°C and evaporated under brine. After evaporation to dryness, the yellow powder was dissolved in 5 ml of CH2C12and 0.5 ml of anisole, and 0.5 ml of TFAwas added to the solution under ice cooling. The reaction mixture was stirred for 1 hour at 0°C, evaporated and solidified with ether. The solid was dissolved in 2 ml of water and chromatographed on Diaion HP-10 to afford 14. The physical data of 14 were shown in Table1. (
To a solution of 570 mg of 12 in 10 ml of DMFwere added 220mg of 4-mercaptopyridine and 0.2 ml of triethylamine. The reaction mixture was stirred for 4 hours at 50°C and evaporated. The residue was dissolved in EtOAc and washed with water and brine. After removal of solvent, the residual yellow solid was dissolved in 5 ml of CH2C12 and 0.2 ml of methyliodide was added to the solution. The reaction mixture was stirred overnight and evaporated to dryness. To the residue were added 5 ml of CH2C12, 0.5 ml of anisole and 5 ml of TFAunder ice cooling. The solution was allowed to react for 1 hour and evaporated. The product was subjected to column chromatography on Diaion HP-10 to afford 14c as brown powder (140mg, 31.6%): XH NMR (D2O) To a solution of 500 mg of cefaclor (1) in 50 ml of THF and 50 ml of water adjusting to pH 7.5 with triethylamine was added 840 mg of di-ter£-butyl-dicarbonate under ice cooling. After stirring for 4 hours, the reaction mixture was acidified with 1 n HC1 to pH 2.5 and extracted twice with EtOAc. The organic layer was collected, washed with brine and evaporated. The residual solid was dissolved in 20 ml of THF, and 750 mg of diphenyldiazomethane was added to the solution. The reaction mixture was stirred 1 hour and evaporated. The product was purified by column chromatography on silica gel to give 15 as colorless powder (800 7-[(jR)-Phenylglycylamino]-3 -(4-pyridylthio)-3 -cephem-2-carboxylic Acid (17b) To a solution of 500 mg of 15 in 10 ml of DMSOwere added 4 equivalents of 4-mercaptopyridine and 2 equivalents of NaHSO3. After stirring for 1 hour, 2 equivalents of NaHSO3was added to the solution, and the stirring was continued for 4 hours at room temperature. EtOAcand water were added to the reaction mixture. The organic layer was separated, washed twice with water and brine, and evaporated. The residue was dissolved in 8 ml of CH2C12 and 0.4ml of anisole, and 8 ml of TFAwas added to the solution under ice cooling. The reaction mixture was stirred for 30 minutes at 0°C, diluted with 100 ml of toluene and evaporated. The residue was solidified with ether and dissolved in 4 ml of water adjusting to pH 4.8 with triethylamine.
The precipitates formed by addition of 4 ml of acetone was chromatographed on Diaion HP-10 to afford 17a (94 mg, 30.7%): *H NMR
